CZ282759B6 - Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje - Google Patents

Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje Download PDF

Info

Publication number
CZ282759B6
CZ282759B6 CZ94395A CZ39594A CZ282759B6 CZ 282759 B6 CZ282759 B6 CZ 282759B6 CZ 94395 A CZ94395 A CZ 94395A CZ 39594 A CZ39594 A CZ 39594A CZ 282759 B6 CZ282759 B6 CZ 282759B6
Authority
CZ
Czechia
Prior art keywords
isatinoxime
group
formula
branched
carbon atoms
Prior art date
Application number
CZ94395A
Other languages
Czech (cs)
English (en)
Other versions
CZ39594A3 (en
Inventor
Frank Watjen
Bjarne Hugo Dahl
Jorgen Drejer
Leif Helth Jensen
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of CZ39594A3 publication Critical patent/CZ39594A3/cs
Publication of CZ282759B6 publication Critical patent/CZ282759B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
CZ94395A 1991-08-28 1992-08-27 Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje CZ282759B6 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75116591A 1991-08-28 1991-08-28
US83185192A 1992-02-05 1992-02-05
PCT/EP1992/001999 WO1993005043A1 (en) 1991-08-28 1992-08-27 Novel isatinoxime derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
CZ39594A3 CZ39594A3 (en) 1994-11-16
CZ282759B6 true CZ282759B6 (cs) 1997-09-17

Family

ID=27115380

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ94395A CZ282759B6 (cs) 1991-08-28 1992-08-27 Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje

Country Status (18)

Country Link
EP (1) EP0529636B1 (enrdf_load_stackoverflow)
JP (1) JP3170584B2 (enrdf_load_stackoverflow)
KR (1) KR100277481B1 (enrdf_load_stackoverflow)
AT (1) ATE181552T1 (enrdf_load_stackoverflow)
AU (1) AU655672B2 (enrdf_load_stackoverflow)
CA (1) CA2076948C (enrdf_load_stackoverflow)
CZ (1) CZ282759B6 (enrdf_load_stackoverflow)
DE (1) DE69229461T2 (enrdf_load_stackoverflow)
DK (1) DK0529636T3 (enrdf_load_stackoverflow)
FI (1) FI107156B (enrdf_load_stackoverflow)
GE (1) GEP20002329B (enrdf_load_stackoverflow)
HU (2) HUT70753A (enrdf_load_stackoverflow)
MX (1) MX9204914A (enrdf_load_stackoverflow)
NO (1) NO301117B1 (enrdf_load_stackoverflow)
PL (1) PL170920B1 (enrdf_load_stackoverflow)
RU (1) RU2114827C1 (enrdf_load_stackoverflow)
SK (1) SK280578B6 (enrdf_load_stackoverflow)
WO (1) WO1993005043A1 (enrdf_load_stackoverflow)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009000A1 (en) 1992-10-13 1994-04-28 Warner-Lambert Company Quinoxalinedione derivatives as eaa antagonists
US5843945A (en) * 1993-05-13 1998-12-01 Neurosearch A/S AMPA antagonists and a method of treatment
CA2161783C (en) * 1993-05-13 2006-08-15 Frank Watjen Ampa antagonists and a method of treatment therewith
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
ATE188701T1 (de) * 1994-09-14 2000-01-15 Neurosearch As Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten
AU687255B2 (en) * 1994-09-14 1998-02-19 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
EP1183025B1 (en) 1999-05-19 2009-01-14 PainCeptor Pharma Corp. Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
CA2394292A1 (en) 2000-01-24 2001-08-02 Neurosearch A/S Isatine derivatives with neurotrophic activity
WO2004039372A1 (en) 2002-10-29 2004-05-13 Sungkyunkwan University Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine
CA2630617C (en) 2005-11-23 2014-03-25 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
JP6393273B2 (ja) 2012-12-19 2018-09-19 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 殺菌剤としてのジフルオロメチル−ニコチン酸−インダニルカルボキサミド類
CN106061938B (zh) * 2014-02-28 2019-04-12 住友化学株式会社 2-(卤代甲基)-3-甲基硝基苯的制造方法
AU2017232377C1 (en) 2016-03-17 2022-05-19 Fmc Ip Technology Gmbh Process for converting S-enantiomer to its racemic form
CN109776451B (zh) * 2017-11-15 2020-12-11 中山光禾医疗科技有限公司 光交联水凝胶材料的制备、原料、产品及应用
CN108912127B (zh) * 2018-08-27 2019-12-10 青岛农业大学 一种基于靛红骨架的苯并[b,e]氮杂卓化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use

Also Published As

Publication number Publication date
MX9204914A (es) 1993-07-01
SK23894A3 (en) 1994-12-07
CZ39594A3 (en) 1994-11-16
DK0529636T3 (da) 1999-12-13
JP3170584B2 (ja) 2001-05-28
RU2114827C1 (ru) 1998-07-10
HU211632A9 (en) 1995-12-28
FI107156B (fi) 2001-06-15
KR100277481B1 (ko) 2001-02-01
AU655672B2 (en) 1995-01-05
NO301117B1 (no) 1997-09-15
JPH06510056A (ja) 1994-11-10
NO940676L (enrdf_load_stackoverflow) 1994-04-27
EP0529636B1 (en) 1999-06-23
DE69229461T2 (de) 1999-10-21
NO940676D0 (no) 1994-02-25
EP0529636A1 (en) 1993-03-03
HUT70753A (en) 1995-10-30
GEP20002329B (en) 2000-12-25
FI940889A0 (fi) 1994-02-25
FI940889A7 (fi) 1994-02-25
ATE181552T1 (de) 1999-07-15
CA2076948A1 (en) 1993-03-01
WO1993005043A1 (en) 1993-03-18
CA2076948C (en) 2002-04-16
AU2482092A (en) 1993-04-05
DE69229461D1 (de) 1999-07-29
HU9400595D0 (en) 1994-05-30
SK280578B6 (sk) 2000-04-10
PL170920B1 (pl) 1997-02-28

Similar Documents

Publication Publication Date Title
CZ282759B6 (cs) Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
EP0587473B1 (fr) Dérivés condensés de la pyridine comme inhibiteurs de l'effet des radicaux libres
KR100192641B1 (ko) 하이드라존 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
EP0059391A1 (de) Imidazodiazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
NO154883B (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner.
DK164704B (da) 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne
Hussenether et al. Clozapine derived 2, 3-dihydro-1H-1, 4-and 1, 5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing
Walser et al. Pentacyclic triazolodiazepines as PAF‐antagonists
JP3010558B2 (ja) 新規の１，７‐融合１ｈ‐インドール‐２‐カルボン酸‐ｎ‐（１，４‐ベンゾジアゼピン‐３‐イル）‐アミド、その製法及びこれを含有するコレシストキニン拮抗作用薬剤
JPH0311067A (ja) 興奮性アミノ酸拮抗剤
US5436250A (en) Isatineoxime derivatives, their preparation and use
US5242918A (en) Isatinoxime derivatives, their preparation and use
DE3587556T2 (de) 2-Substituierte Aminomethyl-1,4-benzodiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
US20020198191A1 (en) Cyclohexylphenyl vasopressin agonists
CS226743B2 (en) Method of preparing new 1,4,9,10-tetrahydropyrazolo (4,3-e)pyrido (3,2-b) l,4)diazepin-10-ones
JPH09512025A (ja) ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体
US6602865B1 (en) Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone and -diazepinone compounds
JP2001512124A (ja) 新規な２，３−ベンゾジアゼピン誘導体
JP3781698B2 (ja) 新規ピリミジン−４−オン化合物、その調製方法、およびそれらを含む医薬組成物
AU762526B2 (en) Novel type condensed pyridazinone compounds
CN114671829B (zh) 以茚酮和二苯并氮杂卓为母核的杂二联体及其盐酸盐、其制备方法和用途
WO1993008166A1 (en) Benzo-isoquinoline derivatives and analogs and their use in therapeutics
HUP0100751A2 (hu) Új aril-vagy heteroaril-kinolinilfoszfonsav-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
AT395155B (de) Verfahren zur herstellung von neuen imidazo(1,5-a)(1,4)diazepinverbindungen
LU84775A1 (fr) Nouveaux derives cycloaliphatiques condenses de pyrido(1,2-a)pyrimidines substituees

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20030827